F M LaForce. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultAgedCost-Benefit AnalysisHumansImmunization, Secondary/economicsImmunization, Secondary/standardsMiddle AgedTetanus/prevention & controlTetanus Toxoid/administration & dosageTetanus Toxoid/economics
Substances: See more » Tetanus Toxoid
Year: 1993 PMID: 8410414 DOI: 10.1007/bf02599628
Source DB: PubMed Journal: J Gen Intern Med ISSN: 0884-8734 Impact factor: 5.128